A detailed history of Alkeon Capital Management LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 3,804,096 shares of ORIC stock, worth $39.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,804,096
Previous 3,704,096 2.7%
Holding current value
$39.2 Million
Previous $50.9 Million 47.2%
% of portfolio
0.04%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.63 - $12.93 $663,000 - $1.29 Million
100,000 Added 2.7%
3,804,096 $26.9 Million
Q1 2024

May 14, 2024

BUY
$8.04 - $16.03 $803,999 - $1.6 Million
100,000 Added 2.77%
3,704,096 $50.9 Million
Q4 2023

Feb 13, 2024

BUY
$5.41 - $9.43 $675,205 - $1.18 Million
124,807 Added 3.59%
3,604,096 $33.2 Million
Q3 2023

Nov 13, 2023

BUY
$6.05 - $9.28 $3.03 Million - $4.64 Million
500,000 Added 16.78%
3,479,289 $21 Million
Q2 2023

Aug 11, 2023

BUY
$4.95 - $8.4 $2.87 Million - $4.87 Million
580,037 Added 24.18%
2,979,289 $23.1 Million
Q4 2022

Feb 13, 2023

BUY
$2.41 - $5.89 $704,404 - $1.72 Million
292,284 Added 13.87%
2,399,252 $14.1 Million
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.07 $540,000 - $1.41 Million
200,000 Added 10.49%
2,106,968 $9.44 Million
Q1 2022

May 16, 2022

BUY
$4.54 - $16.1 $2.18 Million - $7.73 Million
480,000 Added 33.64%
1,906,968 $10.2 Million
Q4 2021

Feb 14, 2022

BUY
$12.01 - $20.3 $5.16 Million - $8.73 Million
429,979 Added 43.13%
1,426,968 $21 Million
Q2 2021

Aug 16, 2021

SELL
$17.37 - $25.34 $18,620 - $27,164
-1,072 Reduced 0.11%
996,989 $17.6 Million
Q1 2021

May 17, 2021

BUY
$23.67 - $36.85 $2.37 Million - $3.69 Million
100,000 Added 11.14%
998,061 $24.5 Million
Q4 2020

Feb 16, 2021

BUY
$20.32 - $39.8 $12.1 Million - $23.7 Million
595,000 Added 196.33%
898,061 $30.4 Million
Q3 2020

Nov 16, 2020

BUY
$19.5 - $31.26 $5.91 Million - $9.47 Million
303,061 New
303,061 $7.58 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $408M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.